Prestige Consumer Healthcare Inc. (PBH) Social Stream
PRESTIGE CONSUMER HEALTHCARE INC (PBH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRESTIGE CONSUMER HEALTHCARE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 4 | $65 | $61 | $63 | $61.22 | 2.91% |
| 2022-02-07 | 4 | $65 | $63 | $64 | $61.22 | 4.54% |
| 2022-05-09 | 4 | $65 | $60 | $62.5 | $61.22 | 2.09% |
| 2022-08-04 | 4 | $70 | $60 | $64.333 | $61.22 | 5.08% |
| 2022-08-09 | 5 | $112 | $60 | $77.5 | $61.22 | 26.59% |
| 2022-09-27 | 5 | $112 | $60 | $78.333 | $61.22 | 27.95% |
| 2022-11-07 | 5 | $112 | $60 | $76.25 | $61.22 | 24.55% |
| 2022-11-17 | 6 | $112 | $60 | $75.2 | $61.22 | 22.84% |
| 2023-02-06 | 6 | $112 | $60 | $77 | $61.22 | 25.78% |
| 2023-05-08 | 6 | $112 | $60 | $76.8 | $61.22 | 25.45% |
| 2023-08-03 | 6 | $79 | $60 | $70 | $61.22 | 14.34% |
| 2023-08-08 | 5 | $79 | $60 | $70 | $61.22 | 14.34% |
| 2023-11-07 | 4 | $79 | $60 | $70 | $61.22 | 14.34% |
The Trend in the Analyst Price Target
Over the past 32 months, PBH's average price target has gone up $22.25.
PBH reports an average of 19.36% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-13 | 6 | 112 | 60 | 77.0 | 66.62 | 15.58% |
| 2023-02-06 | 6 | 112 | 60 | 77.0 | 60.82 | 26.6% |
| 2023-05-08 | 6 | 112 | 60 | 78.4 | 59.50 | 31.76% |
| 2023-05-08 | 6 | 112 | 60 | 76.8 | 59.50 | 29.08% |
| 2023-08-03 | 6 | 112 | 60 | 78.4 | 66.52 | 17.86% |
PBH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 17 months, PBH's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PRESTIGE CONSUMER HEALTHCARE INC's variance in analysts' estimates is lower than -548.35% of all US stocks.
- In terms of how PRESTIGE CONSUMER HEALTHCARE INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 312.75% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PRESTIGE CONSUMER HEALTHCARE INC's upside potential (average analyst target price relative to current price) is greater than 323.78% of them.
- PBH has a greater average analyst price target than 1262.37% of Pharmaceutical Products stocks.
Stocks similar to PRESTIGE CONSUMER HEALTHCARE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FOLD, CORT, and INVA.
View All Top Stocks by Price Target
Is PBH a Buy, Hold or Sell? See the POWR Ratings now!